in this issue
Regions :: Western Europe :: Germany
Secondary Buyout for Specialty Firm
12:32 PM MDT | July 23, 2007 | Chemical Week Editorial Staff
Axa Private Equity (Paris) has acquired more than 70% of specialty chemicals producer Cabb (Sulzbach, Germany) from private equity firm Gilde (Utrecht, the Netherlands). The rest is held by Cabb’s management. Cabb makes monochloroacetic acid and a range of specialty intermediates, and has sales of €140 million/year ($182 million). Its production is at Gersthofen and Knapsack, Germany. Gilde bought the business from Clariant in 2005. Cabb is Axa’s second specialties acquisition in the space of six months following the purchase of Eliokem...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: